Efficacy and safety of transsylvian approach microsurgery in the treatment of hypertensive intracerebral hemorrhage

Objective To investigate the efficacy and safety of transsylvian approach microsurgery in the treatment of patients with hypertensive intracerebral hemorrhage. Methods A total of 106 patients with hypertensive intracerebral hemorrhage who were treated in Pingmei Shenma Group General Hospital from January 2016 to September 2019 were enrolled and divided into the control group and observation group by random number table method, with 53 cases in each group. Patients in the control group were treated by small bone window craniotomy, and patients in the observation group were treated by transsylvian approach microsurgery. The treatment outcomes of the two groups were recorded and compared. Results After treatment, the recovery rate of the observation group was 98.11% (52/53), higher than the 62.26% (33/53) of the control group (P<0.05). However, the severe disability rate was 1.89% (1/53) in the observation group, lower than the 33.96% (18/53) in the control group (P<0.05). Compared with the control group, the observation group had better outcomes in the health index, emotional score, social index, life satisfaction and other quality of life indicators (P<0.05). The incidence of adverse reactions, such as stress ulcer, hydrocephalus and re-bleeding, in the observation group was 3.77%(2/53), lower than the 15.09% (8/53) in the control group (P<0.05). Conclusions In the clinical treatment of patients with hypertensive intracerebral hemorrhage, transsylvian approach microsurgery can alleviate symptoms, promote quality of life, with low incidence of adverse reactions. Key words: Hypertension; Cerebral hemorrhage; Transsylvian approach microsurgery; Effectiveness; Safety